Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Strategies for eliciting and synthesizing evidence for guidelines in rare diseases.

Pai M, Yeung CHT, Akl EA, Darzi A, Hillis C, Legault K, Meerpohl JJ, Santesso N, Taruscio D, Verhovsek M, Sch√ľnemann HJ, Iorio A.

BMC Med Res Methodol. 2019 Mar 28;19(1):67. doi: 10.1186/s12874-019-0713-0.

2.

Competition between mobile genetic elements drives optimization of a phage-encoded CRISPR-Cas system: insights from a natural arms race.

McKitterick AC, LeGault KN, Angermeyer A, Alam M, Seed KD.

Philos Trans R Soc Lond B Biol Sci. 2019 May 13;374(1772):20180089. doi: 10.1098/rstb.2018.0089.

3.

Genome Editing Method for the Anaerobic Magnetotactic Bacterium Desulfovibrio magneticus RS-1.

Grant CR, Rahn-Lee L, LeGault KN, Komeili A.

Appl Environ Microbiol. 2018 Oct 30;84(22). pii: e01724-18. doi: 10.1128/AEM.01724-18. Print 2018 Nov 15.

4.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

5.

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.

Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14192. [Epub ahead of print]

PMID:
29978552
6.

Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous.

Ocampo V, Haaland D, Legault K, Mittoo S, Aitken E.

BMJ Case Rep. 2016 Aug 8;2016. pii: bcr2016215423. doi: 10.1136/bcr-2016-215423.

7.

Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Legault KJ, Ugarte A, Crowther MA, Ruiz-Irastorza G.

Curr Rheumatol Rep. 2016 May;18(5):26. doi: 10.1007/s11926-016-0573-0. Review.

PMID:
27032789
8.

Quality of discharge summaries prepared by first year internal medicine residents.

Legault K, Ostro J, Khalid Z, Wasi P, You JJ.

BMC Med Educ. 2012 Aug 15;12:77. doi: 10.1186/1472-6920-12-77.

9.

Amyloidosis and giant cell arteritis/polymyalgia rheumatica.

Legault K, Shroff A, Crowther M, Khalidi N.

J Rheumatol. 2012 Apr;39(4):878-80. doi: 10.3899/jrheum.111013. No abstract available.

PMID:
22467956
10.

Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.

Hatton MW, Southward SM, Legault KJ, Ross BL, Clarke BJ, Bajzar L, Blajchman MA, Singh G, Richardson M.

J Lab Clin Med. 2004 Apr;143(4):241-54.

PMID:
15085083
11.

Angiostatin II is the predominant glycoform in pleural effusates of rabbit VX-2 lung tumors.

Hatton MW, Southward SM, Ross BL, Legault K, Marien L, Korbie D, Richardson M, Singh G, Clarke BJ, Blajchman MA.

J Lab Clin Med. 2002 May;139(5):316-23.

PMID:
12032493

Supplemental Content

Loading ...
Support Center